These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3013865)

  • 1. Effects of beta-adrenergic stimulation on 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
    Fisher RA; Kumar R; Hanahan DJ; Olson MS
    J Biol Chem; 1986 Jul; 261(19):8817-23. PubMed ID: 3013865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
    Buxton DB; Hanahan DJ; Olson MS
    Biochem Pharmacol; 1986 Mar; 35(6):893-7. PubMed ID: 3754140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine.
    Buxton DB; Shukla SD; Hanahan DJ; Olson MS
    J Biol Chem; 1984 Feb; 259(3):1468-71. PubMed ID: 6693418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid.
    Lapointe DS; Olson MS
    J Biol Chem; 1989 Jul; 264(21):12130-3. PubMed ID: 2501299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic inhibition of AGEPC-stimulated Na+/Ca2+ exchange and AGEPC-induced platelet activation.
    Kester M; Fisher RA; Olson MS
    Biochim Biophys Acta; 1989 Nov; 1014(2):195-202. PubMed ID: 2554977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitric oxide on platelet-activating factor- and alpha-adrenergic-stimulated vasoconstriction and glycogenolysis in the perfused rat liver.
    Moy JA; Bates JN; Fisher RA
    J Biol Chem; 1991 May; 266(13):8092-6. PubMed ID: 1673678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of hepatic calcium pools by platelet activating factor.
    Lapointe DS; Hanahan DJ; Olson MS
    Biochemistry; 1987 Mar; 26(6):1568-74. PubMed ID: 3593678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
    Buxton DB; Fisher RA; Hanahan DJ; Olson MS
    J Biol Chem; 1986 Jan; 261(2):644-9. PubMed ID: 3001074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet-activating factor receptor and platelet-activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells.
    Chao W; Liu HL; Zhou WG; Hanahan DJ; Olson MS
    J Biol Chem; 1990 Oct; 265(29):17576-83. PubMed ID: 2170386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-adrenergic agonist regulation of immune aggregate- and platelet-activating factor-stimulated hepatic metabolism.
    Steinhelper ME; Fisher RA; Revtyak GE; Hanahan DJ; Olson MS
    J Biol Chem; 1989 Jul; 264(19):10976-81. PubMed ID: 2544577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin, a potent peptide agonist in the liver.
    Gandhi CR; Stephenson K; Olson MS
    J Biol Chem; 1990 Oct; 265(29):17432-5. PubMed ID: 2211635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF increases hepatic vascular resistance and glycogenolysis in vivo.
    Hines KL; Braillon A; Fisher RA
    Am J Physiol; 1991 Mar; 260(3 Pt 1):G471-80. PubMed ID: 1848410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619.
    Fisher RA; Robertson SM; Olson MS
    J Biol Chem; 1987 Apr; 262(10):4631-8. PubMed ID: 3558359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immune-aggregate-stimulated hepatic glycogenolysis and vasoconstriction by vicinal dithiols.
    Steinhelper ME; Olson MS
    Biochem J; 1988 Feb; 249(3):631-7. PubMed ID: 3355492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of platelet activating factor binding in rat liver.
    Hill CE; Miwa M; Sheridan PJ; Hanahan DJ; Olson MS
    Biochem J; 1988 Aug; 253(3):651-7. PubMed ID: 3178735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of hepatic tissue spaces by platelet-activating factor and phenylephrine.
    Lapointe DS; Olson MS
    Hepatology; 1989 Feb; 9(2):278-84. PubMed ID: 2643546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium.
    Hill CE; Olson MS
    Biochem J; 1987 Oct; 247(1):207-14. PubMed ID: 3689345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in glucose and lactate output and perfusion resistance by stimulation of hepatic nerves in isolated perfused rat liver: role of alpha 1-, alpha 2-, beta 1- and beta 2-receptors.
    Ulken V; Püschel GP; Jungermann K
    Biol Chem Hoppe Seyler; 1991 Jun; 372(6):401-9. PubMed ID: 1654928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of glycogenolysis and platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver.
    Buxton DB; Hanahan DJ; Olson MS
    J Biol Chem; 1984 Nov; 259(22):13758-61. PubMed ID: 6501277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of essential fatty acid deficiency on the adrenergic activation of glycogenolysis in rat hepatocytes.
    Grojec MS; Ishac EJ; Kapocsi J; Kunos G
    Arch Biochem Biophys; 1990 Nov; 283(1):34-9. PubMed ID: 2173490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.